Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Polio and Measles Down the Drain: Environmental Enterovirus Surveillance in the Netherlands, 2005 to 2015.

Benschop KSM, van der Avoort HG, Jusic E, Vennema H, van Binnendijk R, Duizer E.

Appl Environ Microbiol. 2017 Jun 16;83(13). pii: e00558-17. doi: 10.1128/AEM.00558-17. Print 2017 Jul 1.

2.

Antiviral Activity of Pocapavir in a Randomized, Blinded, Placebo-Controlled Human Oral Poliovirus Vaccine Challenge Model.

Collett MS, Hincks JR, Benschop K, Duizer E, van der Avoort H, Rhoden E, Liu H, Oberste MS, McKinlay MA, Hartford M.

J Infect Dis. 2017 Feb 1;215(3):335-343. doi: 10.1093/infdis/jiw542.

3.

VIRO-TypeNed, systematic molecular surveillance of enteroviruses in the Netherlands between 2010 and 2014.

Benschop KS, Rahamat-Langendoen JC, van der Avoort HG, Claas EC, Pas SD, Schuurman R, Verweij JJ, Wolthers KC, Niesters HG, Koopmans MP; VIRO-TypeNed.

Euro Surveill. 2016 Sep 29;21(39). doi: 10.2807/1560-7917.ES.2016.21.39.30352.

4.

Antivirals against enteroviruses: a critical review from a public-health perspective.

Benschop KS, van der Avoort HG, Duizer E, Koopmans MP.

Antivir Ther. 2015;20(2):121-30. doi: 10.3851/IMP2939. Epub 2015 Jan 26. Review.

PMID:
25643052
5.

Continued seasonal circulation of enterovirus D68 in the Netherlands, 2011-2014.

Meijer A, Benschop KS, Donker GA, van der Avoort HG.

Euro Surveill. 2014 Oct 23;19(42). pii: 20935.

6.

Immunity against poliomyelitis in the Netherlands, assessed in 2006 to 2007: the importance of completing a vaccination series.

van der Maas NA, Mollema L, Berbers GA, van Rooijen DM, van der Avoort HG, Conyn-Van Spaendonck MA, de Melker HE, van der Klis FR.

Euro Surveill. 2014 Feb 20;19(7):20705.

7.

Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination.

Wright PF, Wieland-Alter W, Ilyushina NA, Hoen AG, Arita M, Boesch AW, Ackerman ME, van der Avoort H, Oberste MS, Pallansch MA, Burton AH, Jaffar MA, Sutter RW.

J Infect Dis. 2014 May 15;209(10):1628-34. doi: 10.1093/infdis/jit671. Epub 2014 Jan 23.

PMID:
24459191
8.

Detection of human enteroviruses and parechoviruses as part of the national enterovirus surveillance in the Netherlands, 1996-2011.

van der Sanden SM, Koopmans MP, van der Avoort HG.

Eur J Clin Microbiol Infect Dis. 2013 Dec;32(12):1525-31. doi: 10.1007/s10096-013-1906-9. Epub 2013 Jun 19.

PMID:
23780695
9.

Authors reply: Application of bayesian methods to the inference of phylogeny for enterovirus surveillance.

Koopmans M, Niesters HG, Benschop K, Wolthers K, Schuurman R, Pas SD, Claas EC, Kroneman A, Rahamat-Langendoen JC, Vennema H, van der Avoort H.

Euro Surveill. 2013 Feb 28;18(9). pii: 20410. No abstract available.

10.

September through October 2010 multi-centre study in the Netherlands examining laboratory ability to detect enterovirus 68, an emerging respiratory pathogen.

Jaramillo-Gutierrez G, Benschop KS, Claas EC, de Jong AS, van Loon AM, Pas SD, Pontesilli O, Rossen JW, Swanink CM, Thijsen S, van der Zanden AG, van der Avoort HG, Koopmans MP, Meijer A.

J Virol Methods. 2013 Jun;190(1-2):53-62. doi: 10.1016/j.jviromet.2013.02.010. Epub 2013 Mar 1.

PMID:
23458694
11.

Rapid and accurate identification of poliovirus strains used for vaccine production.

Nijst OE, Mouthaan JJ, Mekkes DR, Jusic E, van der Avoort HG, Metz B.

J Virol Methods. 2013 Apr;189(1):189-95. doi: 10.1016/j.jviromet.2013.01.026. Epub 2013 Feb 19.

PMID:
23434540
12.

Laboratory-based surveillance in the molecular era: the TYPENED model, a joint data-sharing platform for clinical and public health laboratories.

Niesters HG, Rossen JW, van der Avoort H, Baas D, Benschop K, Claas EC, Kroneman A, van Maarseveen N, Pas S, van Pelt W, Rahamat-Langendoen JC, Schuurman R, Vennema H, Verhoef L, Wolthers K, Koopmans M.

Euro Surveill. 2013 Jan 24;18(4):20387.

13.

Emergence and epidemic occurrence of enterovirus 68 respiratory infections in The Netherlands in 2010.

Meijer A, van der Sanden S, Snijders BE, Jaramillo-Gutierrez G, Bont L, van der Ent CK, Overduin P, Jenny SL, Jusic E, van der Avoort HG, Smith GJ, Donker GA, Koopmans MP.

Virology. 2012 Feb 5;423(1):49-57. doi: 10.1016/j.virol.2011.11.021. Epub 2011 Dec 15.

14.

Role of environmental poliovirus surveillance in global polio eradication and beyond.

Hovi T, Shulman LM, van der Avoort H, Deshpande J, Roivainen M, DE Gourville EM.

Epidemiol Infect. 2012 Jan;140(1):1-13. doi: 10.1017/S095026881000316X. Epub 2011 Aug 18. Review.

PMID:
21849095
15.

Detection of recombination breakpoints in the genomes of human enterovirus 71 strains isolated in the Netherlands in epidemic and non-epidemic years, 1963-2010.

van der Sanden S, van Eek J, Martin DP, van der Avoort H, Vennema H, Koopmans M.

Infect Genet Evol. 2011 Jul;11(5):886-94. doi: 10.1016/j.meegid.2011.02.011. Epub 2011 Feb 23.

PMID:
21352955
16.

Metagenomic sequencing for virus identification in a public-health setting.

Svraka S, Rosario K, Duizer E, van der Avoort H, Breitbart M, Koopmans M.

J Gen Virol. 2010 Nov;91(Pt 11):2846-56. doi: 10.1099/vir.0.024612-0. Epub 2010 Jul 21.

PMID:
20660148
17.

Fractional doses of inactivated poliovirus vaccine in Oman.

Mohammed AJ, AlAwaidy S, Bawikar S, Kurup PJ, Elamir E, Shaban MM, Sharif SM, van der Avoort HG, Pallansch MA, Malankar P, Burton A, Sreevatsava M, Sutter RW.

N Engl J Med. 2010 Jun 24;362(25):2351-9. doi: 10.1056/NEJMoa0909383.

18.

Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C viruses.

van der Sanden S, van der Avoort H, Lemey P, Uslu G, Koopmans M.

J Gen Virol. 2010 Aug;91(Pt 8):1949-58. doi: 10.1099/vir.0.019695-0. Epub 2010 Apr 7.

PMID:
20375223
19.

Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008.

van der Sanden S, Koopmans M, Uslu G, van der Avoort H; Dutch Working Group for Clinical Virology.

J Clin Microbiol. 2009 Sep;47(9):2826-33. doi: 10.1128/JCM.00507-09. Epub 2009 Jul 22.

20.

Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine.

van der Sanden S, Pallansch MA, van de Kassteele J, El-Sayed N, Sutter RW, Koopmans M, van der Avoort H.

J Virol. 2009 Sep;83(17):8693-704. doi: 10.1128/JVI.02388-08. Epub 2009 Jun 10.

21.

Monovalent type 1 oral poliovirus vaccine in newborns.

el-Sayed N, el-Gamal Y, Abbassy AA, Seoud I, Salama M, Kandeel A, Hossny E, Shawky A, Hussein HA, Pallansch MA, van der Avoort HG, Burton AH, Sreevatsava M, Malankar P, Wahdan MH, Sutter RW.

N Engl J Med. 2008 Oct 16;359(16):1655-65. doi: 10.1056/NEJMoa0800390.

22.

Prevalence of human parechovirus in the Netherlands in 2000 to 2007.

van der Sanden S, de Bruin E, Vennema H, Swanink C, Koopmans M, van der Avoort H.

J Clin Microbiol. 2008 Sep;46(9):2884-9. doi: 10.1128/JCM.00168-08. Epub 2008 Jul 9.

23.

[Poliomyelitis in 2006: all or nothing].

van der Avoort HG.

Ned Tijdschr Geneeskd. 2006 Dec 9;150(49):2689-92. Dutch.

PMID:
17194003
24.

Containment of polioviruses after eradication and OPV cessation: characterizing risks to improve management.

Dowdle W, van der Avoort H, de Gourville E, Delpeyroux F, Desphande J, Hovi T, Martin J, Pallansch M, Kew O, Wolff C.

Risk Anal. 2006 Dec;26(6):1449-69. Review.

PMID:
17184392
25.

Syndromic surveillance in the Netherlands for the early detection of West Nile virus epidemics.

Rockx B, van Asten L, van den Wijngaard C, Godeke GJ, Goehring L, Vennema H, van der Avoort H, van Pelt W, Koopmans M.

Vector Borne Zoonotic Dis. 2006 Summer;6(2):161-9.

PMID:
16796513
26.

Risk of introduction of poliovirus into a Dutch Cape Verdian community during an outbreak of poliovirus in Cape Verde, 2000.

Mertens PL, Widdowson MA, van der Avoort HG, Richardus JH.

Trop Med Int Health. 2006 May;11(5):746-50.

27.

Highly sensitive assay for detection of enterovirus in clinical specimens by reverse transcription-PCR with an armored RNA internal control.

Beld M, Minnaar R, Weel J, Sol C, Damen M, van der Avoort H, Wertheim-van Dillen P, van Breda A, Boom R.

J Clin Microbiol. 2004 Jul;42(7):3059-64.

28.

Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993.

Yang CF, Naguib T, Yang SJ, Nasr E, Jorba J, Ahmed N, Campagnoli R, van der Avoort H, Shimizu H, Yoneyama T, Miyamura T, Pallansch M, Kew O.

J Virol. 2003 Aug;77(15):8366-77.

29.

Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus.

Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib Z, André J, Blackman E, Freeman CJ, Jorba J, Sutter R, Tambini G, Venczel L, Pedreira C, Laender F, Shimizu H, Yoneyama T, Miyamura T, van Der Avoort H, Oberste MS, Kilpatrick D, Cochi S, Pallansch M, de Quadros C.

Science. 2002 Apr 12;296(5566):356-9. Epub 2002 Mar 14.

30.

Poliovirus circulation among schoolchildren during the early phase of the 1992-1993 poliomyelitis outbreak in The Netherlands.

Oostvogel PM, Rumke HC, Conyn-Van Spaendonck MA, van der Avoort HG, Leeuwenburg J, van Loon AM.

J Infect Dis. 2001 Dec 1;184(11):1451-5. Epub 2001 Nov 13.

PMID:
11709788
31.
32.

Lessons from diagnostic investigations of patients with poliomyelitis and their direct contacts for the present surveillance of acute flaccid paralysis.

Herremans T, Koopmans MP, van der Avoort HG, van Loon AM.

Clin Infect Dis. 1999 Oct;29(4):849-54.

PMID:
10589902
33.

Genetic basis for immunological aberrations in poliovirus Sabin serotype 3 strains imported in the netherlands.

Reimerink JH, van der Avoort HG, van Loon AM, Koopmans MP.

J Clin Microbiol. 1999 Aug;37(8):2393-8.

34.

Molecular epidemiology of poliovirus infection in Tunisia.

Triki H, Bahri O, Guillot S, van der Avoort HG, Sassi JB, Arrouji A, Arrouji Z, Slim A, Crainic R, Dellagi K.

J Med Microbiol. 1999 Jun;48(6):569-76.

PMID:
10359306
35.

Australia's last reported case of wild poliovirus infection.

Kennett ML, Brussen KA, Wood DJ, van der Avoort HG, Ras A, Kelly HA.

Commun Dis Intell. 1999 Mar 18;23(3):77-9.

36.

A Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site 1.

Mulders MN, Reimerink JH, Stenvik M, Alaeddinoglu I, van der Avoort HG, Hovi T, Koopmans MP.

J Gen Virol. 1999 Apr;80 ( Pt 4):907-16.

PMID:
10211959
37.

Ending polio immunization: when and how are we sure that the needle is out of the haystack?

Kimman TG, Koopmans MP, van der Avoort HG.

Vaccine. 1999 Feb 26;17(7-8):624-7. Review. No abstract available.

PMID:
10067666
38.

Multicenter evaluation of the Amplicor Enterovirus PCR test with cerebrospinal fluid from patients with aseptic meningitis. The European Union Concerted Action on Viral Meningitis and Encephalitis.

van Vliet KE, Glimâker M, Lebon P, Klapper PE, Taylor CE, Ciardi M, van der Avoort HG, Diepersloot RJ, Kurtz J, Peeters MF, Cleator GM, van Loon AM.

J Clin Microbiol. 1998 Sep;36(9):2652-7.

39.

Antigenic and molecular characterization of wild type 1 poliovirus causing outbreaks of poliomyelitis in Albania and neighboring countries in 1996.

Fiore L, Genovese D, Diamanti E, Catone S, Ridolfi B, Ibrahimi B, Konomi R, van der Avoort HG, Hovi T, Crainic R, Simeoni P, Amato C.

J Clin Microbiol. 1998 Jul;36(7):1912-8.

40.

Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination.

Prevots DR, Ciofi degli Atti ML, Sallabanda A, Diamante E, Aylward RB, Kakariqqi E, Fiore L, Ylli A, van der Avoort H, Sutter RW, Tozzi AE, Panei P, Schinaia N, Genovese D, Oblapenko G, Greco D, Wassilak SG.

Clin Infect Dis. 1998 Feb;26(2):419-25.

PMID:
9502465
41.

Ending polio immunization.

Kimman TF, Koopmans MP, van der Avoort HG.

Science. 1998 Feb 6;279(5352):788-9. No abstract available.

PMID:
9480545
42.

Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization test.

Herremans MM, Reimerink JH, Ras A, Van Der Avoort HG, Kimman TG, Van Loon AM, Conyn-Van Spaendonck MA, Koopmans MP.

Clin Diagn Lab Immunol. 1997 Nov;4(6):659-64.

43.

Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands.

Herremans MM, van Loon AM, Reimerink JH, Rümke HC, van der Avoort HG, Kimman TG, Koopmans MP.

Clin Diagn Lab Immunol. 1997 Sep;4(5):499-503.

44.

Genetic analysis of wild-type poliovirus importation into The Netherlands (1979-1995).

Mulders MN, Reimerink JH, Koopmans MP, van Loon AM, van der Avoort HG.

J Infect Dis. 1997 Sep;176(3):617-24.

PMID:
9291306
45.

['Open season in the hunt for poliovirus' (continued)].

van Loon AM, van der Avoort HG.

Ned Tijdschr Geneeskd. 1997 Jul 19;141(29):1420-4. Review. Dutch.

PMID:
9542865
46.

The molecular epidemiology of type 1 poliovirus in Central African Republic.

Morvan JM, Chezzi C, Gouandjika I, Reimerink JH, van der Avoort HG.

J Gen Virol. 1997 Mar;78 ( Pt 3):591-9.

PMID:
9049410
47.

Molecular characterization of a wild poliovirus type 3 epidemic in The Netherlands (1992 and 1993).

Mulders MN, van Loon AM, van der Avoort HG, Reimerink JH, Ras A, Bestebroer TM, Drebot MA, Kew OM, Koopmans MP.

J Clin Microbiol. 1995 Dec;33(12):3252-6.

48.

Comparative study of five methods for intratypic differentiation of polioviruses.

van der Avoort HG, Hull BP, Hovi T, Pallansch MA, Kew OM, Crainic R, Wood DJ, Mulders MN, van Loon AM.

J Clin Microbiol. 1995 Oct;33(10):2562-6.

49.

Isolation of epidemic poliovirus from sewage during the 1992-3 type 3 outbreak in The Netherlands.

van der Avoort HG, Reimerink JH, Ras A, Mulders MN, van Loon AM.

Epidemiol Infect. 1995 Jun;114(3):481-91.

50.

Molecular epidemiology of wild poliovirus type 1 in Europe, the Middle East, and the Indian subcontinent.

Mulders MN, Lipskaya GY, van der Avoort HG, Koopmans MP, Kew OM, van Loon AM.

J Infect Dis. 1995 Jun;171(6):1399-405.

PMID:
7769273

Supplemental Content

Loading ...
Support Center